🔴 Abivax is trading 4.1% down today with no confirmed company-specific announcement

Abivax is trading at $113.76 (-4.11%), with no confirmed company-specific announcement explaining the September 14 decline.

• Abivax’s half-year results timing appears inconsistent: one company page lists September 14, while newer investor-relations materials list September 21.
• Bank of America reportedly reduced its stake below 5% on September 9, potentially adding selling pressure, though coverage does not directly attribute the session’s decline to the filing.
• Broader markets are only modestly lower, making macro sentiment an insufficient explanation.